Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Philippe A. Cassier"'
Autor:
Jean-Yves Blay, Maud Toulmonde, Claire Cropet, François Bertucci, Julien Gautier, Mathieu Molimard, Antoine Italiano, Maria Rios, Philippe A. Cassier, Isabelle Ray-Coquard, Emmanuelle Chauzit, Nicolas Isambert, Olivier Mir, Olivier Bouché, David Pérol, Antoine Adenis, Axel Le Cesne, Emmanuelle Bompas, Florence Duffaud
Publikováno v:
Lancet Oncology
Lancet Oncology, 2016, 17 (5), pp.632-641. ⟨10.1016/s1470-2045(16)00075-9⟩
Lancet Oncology, 2016, 17 (5), pp.632-641. ⟨10.1016/s1470-2045(16)00075-9⟩
Summary Background Gastrointestinal stromal tumours (GIST) are the most common mesenchymal neoplasms of the gastrointestinal tract. Imatinib followed by sunitinib and regorafenib is the standard sequence of treatment for advanced disease. Pazopanib i
Autor:
Eleonora De Maio, Sylvie Zanetta, C. Terret, Anne-Laure Simonet-Lamm, Sophie Cousin, Juliette Bouchet, Nicolas Penel, Philippe A. Cassier, Nuria Kotecki-Borghesi, Louis Tassy, Nicolas Isambert, Carlos Gomez-Roca, Jean-Pierre Delord
Publikováno v:
Pharmaceutical Medicine. 30:49-55
The selection of patients for phase I cancer trials remains challenging. Patients who dropout of the trial before completion need to be replaced and this can result in significant delays to trial completion. The objective of this study was to identif
Autor:
Sylvie Chabaud, Gualter Vaz, Aurélien Dupré, Jean-Yves Blay, Philippe A. Cassier, Jerome Garret, Marie Karanian, Isabelle Ray-Coquard, Mehdi Brahmi, François Gouin, Armelle Dufresne, Nadège Corradini, Amine Bouhamama, David Pérol, Marie-Pierre Sunyach, Perrine Marec-Berard, Alexandra Meurgey
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 5, p e0233046 (2020)
PLoS ONE, Vol 15, Iss 5, p e0233046 (2020)
Rationale CSF1R tyrosine kinase inhibitors (TKI) and antibodies yield response rates and tumor control in patients with diffuse type tenosynovial giant cell tumors (dTGCT). The long term management of patients with dTGCT treated with TKI is however n
Autor:
Emmanuelle Bompas, Jean-Yves Blay, Carlos Gomez-Roca, Nathalie Gass, Anna-Maria Jegg, Markus Dembowski, Jean-Pierre Delord, Carola Ries, Dominik Rüttinger, Christophe Le Tourneau, Karen Noh, Maud Toulmonde, Anne Brillouet, Lidia Ukarma, Ross Harding, Philippe A. Cassier, Keelara Abiraj, Ann-Marie E Bröske, Katharine Bray-French, Jayantha Ratnayake, Christine Freilinger, Monika Baehner, Michael A. Cannarile, Randolph Christen, Georgina Meneses-Lorente, Antoine Italiano, Claudia Müller
Publikováno v:
The Lancet Oncology. 16:949-956
Summary Background Diffuse-type tenosynovial giant cell tumour (dt-GCT) of the soft tissue (alternatively known as pigmented villonodular synovitis), an orphan disease with unmet medical need, is characterised by an overexpression of colony-stimulati
Autor:
C. Delcambre, E. Stoeckle, S. Bonvalot, Jean-Léon Lagrange, Pierre Meeus, Philippe A. Cassier, Aude Duret, Serge Leyvraz, Guy Kantor, T. Dubergé, Jacques-Olivier Bay, J.-M. Coindre, A. Labib, Jean-Yves Blay, Claude Linassier, Marie-Pierre Sunyach, Emilie Lavergne, C. Le Pechoux, G. Vaz
Publikováno v:
Annals of Oncology. 25:1854-1860
BACKGROUND The role of adjuvant radiotherapy (RT) in the management of atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WD-LPS) remains controversial. METHODS Two hundred eighty-three patients with operable ALT/WD-LPS, no history of pre
Autor:
Anne-Valérie Decouvelaere, Olfa Derbel, François-Noël Gilly, Gualter Vaz, Eric De Laroche, Jean-Yves Blay, Pierre Meeus, Philippe A. Cassier, Philippe Thiesse, Dominique Ranchère-Vince, Claire Cropet, Dominic Cellier, Pierre Heudel, Fadila Farsi, Pierre Biron, Isabelle Ray-Coquard, Olivier Collard
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 2, p e0158406 (2017)
PLoS ONE, Vol 12, Iss 2, p e0158406 (2017)
Purpose The outcome of sarcoma has been suggested in retrospective and non-exhaustive studies to be better through management by a multidisciplinary team of experts and adherence to clinical practice guidelines (CPGs). The aim of this prospective and
Autor:
Alexandra Rauch, Lars H. Lindner, Nina L. Jebsen, Philippe A Cassier, Sebastian Pratschke, Alessandro Gronchi, M. Kirschneck, Markus Albertsmeier, Jens Werner, Claus Belka, Falk Roeder, Martin K. Angele, Paul Sargos, S Hasenhütl
Publikováno v:
Annals of surgical oncology. 25(3)
The aim of this study was to evaluate the role of preoperative and postoperative external beam radiation therapy (EBRT) in the treatment of resectable soft tissue sarcomas (STSs) of different tumor locations. A systematic literature search was perfor
Autor:
Richard H. Wilson, Stan B. Kaye, Andre T. Brunetto, Jean-Charles Soria, Nicolas Penel, Patrick Schöffski, Ruth Plummer, Carlos Gomez-Roca, Josep Tabernero, Silvia Marsoni, Jan H.M. Schellens, Philippe A. Cassier, Jeff Evans, Gianluca Del Conte, Victor Moreno Garcia, Rafael Morales-Barrera, Jaap Verweij, David Olmos, Elisa Gallerani, Emile E. Voest
Publikováno v:
Clinical Cancer Research, 20(22), 5663. American Association for Cancer Research Inc.
Clinical Cancer Research, 20(22), 5663-5671. American Association for Cancer Research Inc.
Clinical Cancer Research, 20(22), 5663-5671. American Association for Cancer Research Inc.
Introduction: Because a dose–response relationship is characteristic of conventional chemotherapy, this concept is widely used for the development of novel cytotoxic (CTX) drugs. However, the need to reach the MTD to obtain optimal benefit with mol
Autor:
Inthidar Labidi Galy, Catherine Sebban, Jean-Yves Blay, Olivier Tredan, Thomas Bachelot, Christophe Borg, Gilles Clapisson, Irène Philip, Claire Cropet, David Pérol, Isabelle Ray-Coquard, Pierre Biron, Sylvie Chabaud, Christine Ménétrier-Caux, Philippe A. Cassier, Christophe Caux, Julien Péron
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2013, 49 (5), pp.1080-9. ⟨10.1016/j.ejca.2012.11.003⟩
European Journal of Cancer, Elsevier, 2013, 49 (5), pp.1080-9. ⟨10.1016/j.ejca.2012.11.003⟩
European Journal of Cancer, 2013, 49 (5), pp.1080-9. ⟨10.1016/j.ejca.2012.11.003⟩
European Journal of Cancer, Elsevier, 2013, 49 (5), pp.1080-9. ⟨10.1016/j.ejca.2012.11.003⟩
International audience; BACKGROUND: Cancer patients with CD4 lymphopenia have an increased risk of severe toxicity after administration of cytotoxic chemotherapy. The impact of CD4 lymphopenia on long term overall survival (OS) of cancer patients was
Publikováno v:
Current treatment options in oncology. 17(2)
Adequate surgical resection remains the treatment of choice for tenosyovial giant cell tumor (TGCT). However, diffuse type TGCT (D-TGCT) is more difficult to resect and has a higher rate of recurrence (up to 50 %), which is often multiple. D-TGCT is